{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:10:07Z","timestamp":1786623007954,"version":"build-2736575974"},"reference-count":81,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["269864"],"award-info":[{"award-number":["269864"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["302977"],"award-info":[{"award-number":["302977"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2013053"],"award-info":[{"award-number":["2013053"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2018035"],"award-info":[{"award-number":["2018035"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2019105"],"award-info":[{"award-number":["2019105"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018529","name":"Alkermes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018529","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005366","name":"Universitetet i Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012446","name":"Akershus Universitetssykehus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bpsc.2025.04.013","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:50:26Z","timestamp":1746726626000},"page":"1166-1176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reward Sensitivity in Patients Receiving Opioid Agonist and Antagonist Treatment for Opioid Use Disorder: An Observational Study"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6021-6714","authenticated-orcid":false,"given":"Martin","family":"Tr\u00f8stheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads Lund","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"Leknes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennja Majid","family":"Hama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias Nikolai","family":"Roland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp Paul","family":"Lobmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin Klemmetsby","family":"Solli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente M.","family":"Weimand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Tanum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Eikemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpsc.2025.04.013_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2022"},{"key":"10.1016\/j.bpsc.2025.04.013_bib2","series-title":"International Classification of Diseases","year":"2019"},{"key":"10.1016\/j.bpsc.2025.04.013_bib3","series-title":"Mind-Altering Drugs, The Science of Subjective Experience","first-page":"217","article-title":"Subjective effects of opioids","author":"Comer","year":"2005"},{"key":"10.1016\/j.bpsc.2025.04.013_bib4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/anae.16069","article-title":"Opioid analgesic effects on subjective well-being in the operating theatre","volume":"78","author":"Eikemo","year":"2023","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bpsc.2025.04.013_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","article-title":"Drug addiction, dysregulation of reward, and allostasis","volume":"24","author":"Koob","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bpsc.2025.04.013_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","article-title":"The neural basis of drug craving: An incentive-sensitization theory of addiction","volume":"18","author":"Robinson","year":"1993","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.bpsc.2025.04.013_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-clinpsy-032816-044957","article-title":"Reward processing, neuroeconomics, and psychopathology","volume":"13","author":"Zald","year":"2017","journal-title":"Annu Rev Clin Psychol"},{"key":"10.1016\/j.bpsc.2025.04.013_bib8","series-title":"La Psychologie Des Sentiments","author":"Ribot","year":"1896"},{"key":"10.1016\/j.bpsc.2025.04.013_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0004867413508455","article-title":"Anhedonia in substance use disorders: A systematic review of its nature, course and clinical correlates","volume":"48","author":"Garfield","year":"2014","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.bpsc.2025.04.013_bib10","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1177\/2167702619855659","article-title":"Anhedonia as a key clinical feature in the maintenance and treatment of opioid use disorder","volume":"7","author":"Kiluk","year":"2019","journal-title":"Clin Psychol Sci"},{"key":"10.1016\/j.bpsc.2025.04.013_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13233","article-title":"Assessment of anhedonia in adults with and without mental illness: A systematic review and meta-analysis","volume":"3","author":"Tr\u00f8stheim","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.bpsc.2025.04.013_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000086176","article-title":"Anhedonia and substance-related symptoms in detoxified substance-dependent subjects: A correlation study","volume":"52","author":"Janiri","year":"2005","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bpsc.2025.04.013_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00952990701877078","article-title":"Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects","volume":"34","author":"Martinotti","year":"2008","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.bpsc.2025.04.013_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2017.03.012","article-title":"Evidence that anhedonia is a symptom of opioid dependence associated with recent use","volume":"177","author":"Garfield","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bpsc.2025.04.013_bib15","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/0269881118791741","article-title":"Dynamic associations between opioid use and anhedonia: A longitudinal study in opioid dependence","volume":"32","author":"Lubman","year":"2018","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.bpsc.2025.04.013_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109551","article-title":"Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis","volume":"238","author":"Santo","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bpsc.2025.04.013_bib17","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/s41386-019-0377-9","article-title":"Intact responses to non-drug rewards in long-term opioid maintenance treatment","volume":"44","author":"Eikemo","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bpsc.2025.04.013_bib18","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1017\/S0033291719002010","article-title":"Anhedonia in chronic pain and prescription opioid misuse","volume":"50","author":"Garland","year":"2020","journal-title":"Psychol Med"},{"key":"10.1016\/j.bpsc.2025.04.013_bib19","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.neubiorev.2012.06.006","article-title":"Neuropsychological consequences of chronic opioid use: A quantitative review and meta-analysis","volume":"36","author":"Baldacchino","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bpsc.2025.04.013_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.neubiorev.2016.09.011","article-title":"Decision-making ability in current and past users of opiates: A meta-analysis","volume":"71","author":"Biernacki","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bpsc.2025.04.013_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax9140","article-title":"Current status of opioid addiction treatment and related preclinical research","volume":"5","author":"Kreek","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.bpsc.2025.04.013_bib22","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/add.14180","article-title":"Extended-release injectable naltrexone for opioid use disorder: A systematic review","volume":"113","author":"Jarvis","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.bpsc.2025.04.013_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","article-title":"Opioid use disorder","volume":"6","author":"Strang","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bpsc.2025.04.013_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1139\/jpn.0605","article-title":"Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence","volume":"31","author":"Dean","year":"2006","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.bpsc.2025.04.013_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/00952990.2010.540281","article-title":"The association between naltrexone treatment and symptoms of depression in opioid-dependent patients","volume":"37","author":"Mysels","year":"2011","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.bpsc.2025.04.013_bib26","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s00213-015-3891-4","article-title":"Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients","volume":"232","author":"Zaaijer","year":"2015","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.bpsc.2025.04.013_bib27","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/00952990.2016.1197231","article-title":"Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant","volume":"42","author":"Krupitsky","year":"2016","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.bpsc.2025.04.013_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/jamapsychiatry.2018.3537","article-title":"Anxiety, depression, and insomnia among adults with opioid dependence treated with extended-release naltrexone vs buprenorphine-naloxone: A randomized clinical trial and follow-up study","volume":"76","author":"Latif","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bpsc.2025.04.013_bib29","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21m14140","article-title":"Co-occurring depression and suicidal ideation in opioid use disorder: Prevalence and response during treatment with buprenorphine-naloxone and injection naltrexone","volume":"83","author":"Na","year":"2022","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bpsc.2025.04.013_bib30","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/npp.2017.58","article-title":"Opioid modulation of value-based decision-making in healthy humans","volume":"42","author":"Eikemo","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bpsc.2025.04.013_bib31","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1007\/s00213-016-4403-x","article-title":"Sweet taste pleasantness is modulated by morphine and naltrexone","volume":"233","author":"Eikemo","year":"2016","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.bpsc.2025.04.013_bib32","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain","volume":"89","author":"Le Merrer","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bpsc.2025.04.013_bib33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s40429-021-00366-8","article-title":"The role of mu-opioids for reward and threat processing in humans: Bridging the gap from preclinical to clinical opioid drug studies","volume":"8","author":"Meier","year":"2021","journal-title":"Curr Addict Rep"},{"key":"10.1016\/j.bpsc.2025.04.013_bib34","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1097\/j.pain.0000000000001043","article-title":"Discovery of endogenous opioid systems: What it has meant for the clinician\u2019s understanding of pain and its treatment","volume":"158","author":"Ballantyne","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.bpsc.2025.04.013_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/10550490290087929","article-title":"Naltrexone and dysphoria: Fact or myth?","volume":"11","author":"Miotto","year":"2002","journal-title":"Am J Addict"},{"key":"10.1016\/j.bpsc.2025.04.013_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-neuro-093019-112252","article-title":"Reward contributions to serotonergic functions","volume":"43","author":"Liu","year":"2020","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.bpsc.2025.04.013_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/npp.2017.126","article-title":"Endocannabinoid regulation of reward and reinforcement through interaction with dopamine and endogenous opioid signaling","volume":"43","author":"Wenzel","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bpsc.2025.04.013_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/add.14455","article-title":"What defines a clinically meaningful outcome in the treatment of substance use disorders: \u2018Getting your life back.\u2019","volume":"114","author":"Ray","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.bpsc.2025.04.013_bib39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3389\/fpsyt.2019.00592","article-title":"Craving in opioid use disorder: From neurobiology to clinical practice","volume":"10","author":"Kakko","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bpsc.2025.04.013_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1741-7015-8-24","article-title":"Transparent and accurate reporting increases reliability, utility, and impact of your research: Reporting guidelines and the EQUATOR Network","volume":"8","author":"Simera","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.bpsc.2025.04.013_bib41","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bpsc.2025.04.013_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40360-016-0061-1","article-title":"Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)","volume":"17","author":"Kun\u00f8e","year":"2016","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.bpsc.2025.04.013_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2021.100728","article-title":"Enablers and hindrances for longer-term abstinence in opioid dependent individuals receiving treatment with extended-release naltrexone: A Norwegian Longitudinal Recovery Trial (NaltRec study)","volume":"21","author":"Weimand","year":"2021","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.bpsc.2025.04.013_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.biopsych.2004.11.026","article-title":"Toward an objective characterization of an anhedonic phenotype: A signal-detection approach","volume":"57","author":"Pizzagalli","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bpsc.2025.04.013_bib45","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1207\/S15374424jccp280309","article-title":"Sensitivity to reward frequency in boys with attention deficit hyperactivity disorder","volume":"28","author":"Tripp","year":"1999","journal-title":"J Clin Child Psychol"},{"key":"10.1016\/j.bpsc.2025.04.013_bib46","first-page":"208","article-title":"EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence","volume":"1","author":"Kokkevi","year":"1995","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.bpsc.2025.04.013_bib47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1192\/bjp.144.4.395","article-title":"Symptoms of emotional distress in a family Planning Service: Stability over a four-week period","volume":"144","author":"Winokur","year":"1984","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bpsc.2025.04.013_bib48","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1162\/neco.2008.12-06-420","article-title":"The diffusion decision model: Theory and data for two-choice decision tasks","volume":"20","author":"Ratcliff","year":"2008","journal-title":"Neural Comput"},{"key":"10.1016\/j.bpsc.2025.04.013_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.1039172","article-title":"A practical introduction to using the drift diffusion model of decision-making in cognitive psychology, neuroscience, and health sciences","volume":"13","author":"Myers","year":"2022","journal-title":"Front Psychol"},{"key":"10.1016\/j.bpsc.2025.04.013_bib50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jpsychires.2008.03.001","article-title":"Reduced hedonic capacity in major depressive disorder: Evidence from a probabilistic reward task","volume":"43","author":"Pizzagalli","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.bpsc.2025.04.013_bib51","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3758\/BF03203619","article-title":"Corrections for extreme proportions and their biasing effects on estimated values of OFD","volume":"27","author":"Hautus","year":"1995","journal-title":"Behav Res Methods Instrum Comput"},{"key":"10.1016\/j.bpsc.2025.04.013_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1192\/bjp.167.1.99","article-title":"A scale for the assessment of hedonic tone the Snaith\u2013Hamilton pleasure scale","volume":"167","author":"Snaith","year":"1995","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bpsc.2025.04.013_bib53","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/0146167212449362","article-title":"Promotion orientation explains why future-oriented people exercise and eat healthy: Evidence from the two-factor Consideration of Future Consequences-14 scale","volume":"38","author":"Joireman","year":"2012","journal-title":"Pers Soc Psychol Bull"},{"key":"10.1016\/j.bpsc.2025.04.013_bib54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/165019702760279242","article-title":"Life satisfaction in 18- to 64-year-old Swedes: In relation to gender, age, partner and immigrant status","volume":"34","author":"Fugl-Meyer","year":"2002","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.bpsc.2025.04.013_bib55","first-page":"1662","article-title":"Use of naltrexone in the treatment of young drug addicts","volume":"123","author":"Waal","year":"2003","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.bpsc.2025.04.013_bib56","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000092115","article-title":"Naltrexone implants \u2013 Duration, tolerability and clinical usefulness: A pilot study","volume":"12","author":"Waal","year":"2006","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.bpsc.2025.04.013_bib58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.32614\/RJ-2014-005","article-title":"The RWiener package: An R package providing distribution functions for the Wiener diffusion model","volume":"6","author":"Wabersich","year":"2014","journal-title":"R J"},{"key":"10.1016\/j.bpsc.2025.04.013_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v034.i02","article-title":"Beta regression in R","volume":"34","author":"Cribari-Neto","year":"2010","journal-title":"J Stat Soft"},{"key":"10.1016\/j.bpsc.2025.04.013_bib60","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1467-9876.2005.00510.x","article-title":"Generalized additive models for location, scale and shape","volume":"54","author":"Rigby","year":"2005","journal-title":"J R Stat Soc C"},{"key":"10.1016\/j.bpsc.2025.04.013_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/ecs2.3940","article-title":"A case for beta regression in the natural sciences","volume":"13","author":"Geissinger","year":"2022","journal-title":"Ecosphere"},{"key":"10.1016\/j.bpsc.2025.04.013_bib62","series-title":"Modern Applied Statistics With S","author":"Venables","year":"2002"},{"key":"10.1016\/j.bpsc.2025.04.013_bib63","first-page":"7","article-title":"Diagnostic checking in regression relationships","volume":"2","author":"Zeileis","year":"2002","journal-title":"R News"},{"key":"10.1016\/j.bpsc.2025.04.013_bib64","author":"Lenth"},{"key":"10.1016\/j.bpsc.2025.04.013_bib65","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3758\/BF03194105","article-title":"A practical solution to the pervasive problems of p values","volume":"14","author":"Wagenmakers","year":"2007","journal-title":"Psychon Bull Rev"},{"key":"10.1016\/j.bpsc.2025.04.013_bib66","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.21105\/joss.01541","article-title":"bayestestR: Describing effects and their uncertainty, existence and significance within the bayesian framework","volume":"4","author":"Makowski","year":"2019","journal-title":"J Open Source Softw"},{"key":"10.1016\/j.bpsc.2025.04.013_bib67","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1093\/pm\/pnab031","article-title":"Reward responsiveness in patients with opioid use disorder on opioid agonist treatment: Role of comorbid chronic pain","volume":"22","author":"Finan","year":"2021","journal-title":"Pain Med"},{"key":"10.1016\/j.bpsc.2025.04.013_bib68","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1038\/s41380-023-02165-1","article-title":"Distinct profiles of anhedonia and reward processing and their prospective associations with quality of life among individuals with mood disorders","volume":"28","author":"Whitton","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bpsc.2025.04.013_bib69","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1177\/0011000016633507","article-title":"Measuring well-being: A review of instruments","volume":"44","author":"Cooke","year":"2016","journal-title":"Couns Psychol"},{"key":"10.1016\/j.bpsc.2025.04.013_bib70","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1440-1614.2002.01012.x","article-title":"Naltrexone in the treatment of heroin dependence: Relationship with depression and risk of overdose","volume":"36","author":"Ritter","year":"2002","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.bpsc.2025.04.013_bib71","first-page":"CD001867","article-title":"Opioid antagonists for alcohol dependence","volume":"12","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpsc.2025.04.013_bib72","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41386-022-01416-z","article-title":"Opioid antagonism in humans: A primer on optimal dose and timing for central mu-opioid receptor blockade","volume":"48","author":"Tr\u00f8stheim","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bpsc.2025.04.013_bib73","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41386-020-0738-4","article-title":"Selective kappa-opioid antagonism ameliorates anhedonic behavior: Evidence from the Fast-Fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)","volume":"45","author":"Pizzagalli","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bpsc.2025.04.013_bib74","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","article-title":"Untangling the complexity of opioid receptor function","volume":"43","author":"Valentino","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bpsc.2025.04.013_bib75","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1037\/abn0000674","article-title":"I feel good? Anhedonia might not mean \u201cwithout pleasure\u201d for people treated for opioid use disorder","volume":"130","author":"Stull","year":"2021","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/j.bpsc.2025.04.013_bib76","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1037\/a0036975","article-title":"Co-occurring depressive and substance use disorders in adolescents: An examination of reward responsiveness during treatment","volume":"24","author":"Boger","year":"2014","journal-title":"J Psychother Integr"},{"key":"10.1016\/j.bpsc.2025.04.013_bib77","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.pnpbp.2011.02.018","article-title":"Deficits in sustaining reward responses in subsyndromal and syndromal major depression","volume":"35","author":"Liu","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bpsc.2025.04.013_bib78","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jad.2015.10.050","article-title":"Anhedonia is associated with blunted reward sensitivity in first-degree relatives of patients with major depression","volume":"190","author":"Liu","year":"2016","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bpsc.2025.04.013_bib79","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jad.2015.05.028","article-title":"Anhedonia in melancholic and non-melancholic depressive disorders","volume":"184","author":"Fletcher","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bpsc.2025.04.013_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108776","article-title":"Long-acting injectable buprenorphine for opioid use disorder: A systematic review of impact of use on social determinants of health","volume":"139","author":"Martin","year":"2022","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.bpsc.2025.04.013_bib81","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biopsych.2019.06.020","article-title":"Medication treatment of opioid use disorder","volume":"87","author":"Bell","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bpsc.2025.04.013_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108183","article-title":"Patients\u2019 perspectives on initiating treatment with extended-release naltrexone (XR-NTX)","volume":"122","author":"Gauthier","year":"2021","journal-title":"J Subst Abuse Treat"}],"container-title":["Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451902225001417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451902225001417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:36:39Z","timestamp":1778888199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451902225001417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":81,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2451902225001417"],"URL":"https:\/\/doi.org\/10.1016\/j.bpsc.2025.04.013","relation":{},"ISSN":["2451-9022"],"issn-type":[{"value":"2451-9022","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reward Sensitivity in Patients Receiving Opioid Agonist and Antagonist Treatment for Opioid Use Disorder: An Observational Study","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry: Cognitive Neuroscience and Neuroimaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpsc.2025.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society of Biological Psychiatry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}